Investment fund acquires 5% stake in Ipsos
The Lac1 fund, managed by Bpifrance on behalf of French and international investors, is dedicated to the long-term support of large listed multinational companies.
Ipsos said that Lac1’s investment was “a further guarantee that Ipsos’ growth ambitions will be supported in the future”.
The Ipsos board of directors will propose a representative of Bpifrance Investissement as a director at the next general meeting of shareholders, which is due to be held in May 2025.
Lac1 said it intends to acquire further Ipsos shares, depending on market conditions, with a target of holding 7% of the company’s capital.
Didier Truchot, chairman of the board and founder at Ipsos, said: “The board of directors of Ipsos considers that the decision of the Lac1 fund to become a major long-term shareholder of the company as an excellent news.
“It is a positive sign of what has been done to strengthen Ipsos’ global position in its core business: providing accurate, clear information and analysis on changes in society and markets. It is also a new guarantee that Ipsos’ ambitions will be supported in the future.”
Nicolas Dufourcq, chief executive officer at Bpifrance, added: “We are delighted that Lac1 fund has become one of the core shareholders of Ipsos, a global leader in the market research industry.
“This investment reflects Lac1 fund commitment to supporting the group over the long term, convinced by its attractive growth perspectives and its innovative potential as artificial intelligence plays an increasingly important role in its activities.”

We hope you enjoyed this article.
Research Live is published by MRS.
The Market Research Society (MRS) exists to promote and protect the research sector, showcasing how research delivers impact for businesses and government.
Members of MRS enjoy many benefits including tailoured policy guidance, discounts on training and conferences, and access to member-only content.
For example, there's an archive of winning case studies from over a decade of MRS Awards.
Find out more about the benefits of joining MRS here.
0 Comments